Variant report
Variant | nsv514063 |
---|---|
Chromosome Location | chr2:40765204-40768032 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:40763799..40765386-chr2:40772496..40774595,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TMEM178-6 | chr2:40767486-40767578 | NONHSAT070281 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564631053 | chr2:40765284-40765285 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532145551 | chr2:40765287-40765288 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs74635975 | chr2:40765288-40765289 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs367625804 | chr2:40765370-40765371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562318793 | chr2:40765372-40765373 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572052533 | chr2:40765400-40765401 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141894537 | chr2:40765429-40765430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34273078 | chr2:40765431-40765432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190674861 | chr2:40765477-40765478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs72936455 | chr2:40765508-40765509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547255122 | chr2:40765530-40765531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571753130 | chr2:40765541-40765542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538784437 | chr2:40765665-40765666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74764217 | chr2:40765666-40765667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114682641 | chr2:40765679-40765680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536654055 | chr2:40765700-40765701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191394779 | chr2:40765709-40765710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183966502 | chr2:40765710-40765711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533725805 | chr2:40765720-40765721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558360851 | chr2:40765722-40765723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552155580 | chr2:40765801-40765802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs576992122 | chr2:40765815-40765816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543935534 | chr2:40765843-40765844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115329817 | chr2:40765848-40765849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564410700 | chr2:40765908-40765909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76440801 | chr2:40765913-40765914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs79046714 | chr2:40765919-40765920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs113450075 | chr2:40765942-40765943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs370941432 | chr2:40765953-40765954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369083654 | chr2:40765955-40765956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561554414 | chr2:40765970-40765971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200319183 | chr2:40765971-40765972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs11124744 | chr2:40765972-40765973 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs547193355 | chr2:40765980-40765981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565306724 | chr2:40765991-40765992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547154343 | chr2:40765996-40765997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564851554 | chr2:40766044-40766045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs550752660 | chr2:40766127-40766128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568649051 | chr2:40766137-40766138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs77120750 | chr2:40766151-40766152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs111937034 | chr2:40766154-40766155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568589377 | chr2:40766164-40766165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569381466 | chr2:40766201-40766202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs532395876 | chr2:40766205-40766206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181379952 | chr2:40766211-40766212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548214936 | chr2:40766225-40766226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs566410709 | chr2:40766285-40766286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533810786 | chr2:40766294-40766295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560534408 | chr2:40766295-40766296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs74506008 | chr2:40766313-40766314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 21364760 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:40757800-40774800 | Weak transcription | Small Intestine | intestine |
2 | chr2:40758800-40767600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
3 | chr2:40759600-40765400 | Enhancers | Fetal Heart | heart |
4 | chr2:40762200-40766600 | Weak transcription | Primary T cells from cord blood | blood |
5 | chr2:40762200-40767600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr2:40762800-40766800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
7 | chr2:40764000-40767200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr2:40765400-40766400 | Weak transcription | Fetal Heart | heart |
9 | chr2:40766400-40768400 | Enhancers | Fetal Heart | heart |
10 | chr2:40766600-40767400 | Enhancers | Primary T cells from cord blood | blood |
11 | chr2:40766800-40767800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
12 | chr2:40767200-40767400 | Enhancers | Duodenum Mucosa | Duodenum |
13 | chr2:40767200-40767800 | Enhancers | Fetal Intestine Small | intestine |
14 | chr2:40767200-40768200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr2:40767400-40767800 | Flanking Active TSS | Duodenum Mucosa | Duodenum |
16 | chr2:40767600-40768200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr2:40767600-40768800 | Strong transcription | Primary neutrophils fromperipheralblood | blood |
18 | chr2:40767800-40768000 | Enhancers | Duodenum Mucosa | Duodenum |
19 | chr2:40767800-40774200 | Weak transcription | Fetal Intestine Small | intestine |
20 | chr2:40768000-40768400 | Flanking Active TSS | Duodenum Mucosa | Duodenum |